firmagon
ferring pharmaceuticals a/s - degarelix - prostatas audzēji - endokrīnā terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
co-diovan 160 mg/12,5 mg apvalkotās tabletes
novartis baltics, sia, latvia - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 160 mg/12,5 mg
co-diovan 160 mg/25 mg apvalkotās tabletes
novartis baltics, sia, latvia - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 160 mg/25 mg
co-diovan 80 mg/12,5 mg apvalkotās tabletes
novartis baltics, sia, latvia - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 80 mg/12,5 mg
co-codamol 60 mg/1000 mg apvalkotās tabletes
actavis group ptc ehf., iceland - codeini phosphas hemihydricus, paracetamolum - apvalkotās tabletes - 60 mg/1000 mg
co-codamol 500 mg/8 mg tabletes
actavis group ptc ehf., iceland - paracetamolum, codeini phosphas hemihydricus - tablete - 500 mg/8 mg
arilin 250 mg apvalkotās tabletes un 100 mg pesāriji, kombinēts iepakojums
dr. august wolff gmbh & co. kg arzneimittel, germany - metronidazols - apvalkotā tablete + pesārijs - 250 mg/100 mg
arilin 100 mg pesāriji
dr. august wolff gmbh & co. kg arzneimittel, germany - metronidazols - pesārijs - 100 mg
arilin rapid 1000 mg pesāriji
dr. august wolff gmbh & co. kg arzneimittel, germany - metronidazols - pesārijs - 1000 mg
co-codamol 30 mg/500 mg apvalkotās tabletes
teva b.v., netherlands - codeini phosphas hemihydricus, paracetamolum - apvalkotā tablete - 30 mg/500 mg